Filing Details

Accession Number:
0001396677-15-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-12 12:26:59
Reporting Period:
2015-08-10
Filing Date:
2015-08-12
Accepted Time:
2015-08-12 12:26:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1050007 Nutraceutical International Corp NUTR Medicinal Chemicals & Botanical Products (2833) 870515089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265856 J Cory Mcqueen C/O Nutraceutical International Corp
1400 Kearns Blvd 2Nd Fl.
Park City UT 84060
Vice President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-10 2,500 $14.22 25,274 No 4 M Direct
Common Stock Disposition 2015-08-10 2,500 $24.85 22,774 No 4 S Direct
Common Stock Acquisiton 2015-08-11 5,000 $14.22 27,774 No 4 M Direct
Common Stock Disposition 2015-08-11 2,900 $24.50 24,874 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-08-10 2,500 $0.00 2,500 $14.22
Common Stock Employee Stock Option (right to buy) Disposition 2015-08-11 5,000 $0.00 5,000 $14.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2005-09-30 2015-09-30 No 4 M Direct
0 2005-09-30 2015-09-30 No 4 M Direct
Footnotes
  1. Exercise of options expiring on September 30, 2015.
  2. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $24.74 to $24.97. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $24.40 to $24.54. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. The options immediately vested at the time of grant.